Hantavirus infections, primarily zoonotic from rodent exposure via urine, droppings, or saliva, rarely sustain efficient human-to-human spread except for the Andes virus strain, which requires prolonged close contact and has caused only limited clusters. The May 2026 Andes virus outbreak aboard the MV Hondius cruise ship produced roughly 12 cases and three deaths before containment, with CDC and WHO assessments confirming very low global risk due to the absence of sustained community transmission or mutations enabling airborne spread. Official surveillance through August 2026 shows no escalation beyond isolated incidents, consistent with historical patterns of focal outbreaks rather than pandemics. Trader consensus at 96% for no pandemic in 2026 reflects this epidemiological profile and lack of enabling conditions. A realistic shift could occur only from unexpected viral evolution boosting transmissibility or an unprecedented rodent-driven surge overwhelming containment, though current data indicate these thresholds remain distant.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedHantavirus pandemic in 2026?
Hantavirus pandemic in 2026?
4% chance
$17,818,697 Vol.
$17,818,697 Vol.
Dec 31, 2026
4% chance
$17,818,697 Vol.
$17,818,697 Vol.
Dec 31, 2026
This market will resolve to "Yes" if the World Health Organization explicitly characterizes Hantavirus, Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS), or a Hantavirus-related outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.Hantavirus infections, primarily zoonotic from rodent exposure via urine, droppings, or saliva, rarely sustain efficient human-to-human spread except for the Andes virus strain, which requires prolonged close contact and has caused only limited clusters. The May 2026 Andes virus outbreak aboard the MV Hondius cruise ship produced roughly 12 cases and three deaths before containment, with CDC and WHO assessments confirming very low global risk due to the absence of sustained community transmission or mutations enabling airborne spread. Official surveillance through August 2026 shows no escalation beyond isolated incidents, consistent with historical patterns of focal outbreaks rather than pandemics. Trader consensus at 96% for no pandemic in 2026 reflects this epidemiological profile and lack of enabling conditions. A realistic shift could occur only from unexpected viral evolution boosting transmissibility or an unprecedented rodent-driven surge overwhelming containment, though current data indicate these thresholds remain distant.
This market will resolve to "Yes" if the World Health Organization explicitly characterizes Hantavirus, Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS), or a Hantavirus-related outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
Market Opened: May 4, 2026, 10:26 AM ET
Volume
$17,818,697End Date
Dec 31, 2026Market Opened
May 4, 2026, 10:26 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if the World Health Organization explicitly characterizes Hantavirus, Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS), or a Hantavirus-related outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.Hantavirus infections, primarily zoonotic from rodent exposure via urine, droppings, or saliva, rarely sustain efficient human-to-human spread except for the Andes virus strain, which requires prolonged close contact and has caused only limited clusters. The May 2026 Andes virus outbreak aboard the MV Hondius cruise ship produced roughly 12 cases and three deaths before containment, with CDC and WHO assessments confirming very low global risk due to the absence of sustained community transmission or mutations enabling airborne spread. Official surveillance through August 2026 shows no escalation beyond isolated incidents, consistent with historical patterns of focal outbreaks rather than pandemics. Trader consensus at 96% for no pandemic in 2026 reflects this epidemiological profile and lack of enabling conditions. A realistic shift could occur only from unexpected viral evolution boosting transmissibility or an unprecedented rodent-driven surge overwhelming containment, though current data indicate these thresholds remain distant.
This market will resolve to "Yes" if the World Health Organization explicitly characterizes Hantavirus, Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS), or a Hantavirus-related outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
Volume
$17,818,697End Date
Dec 31, 2026Market Opened
May 4, 2026, 10:26 AM ETResolver
0x65070BE91...Hantavirus infections, primarily zoonotic from rodent exposure via urine, droppings, or saliva, rarely sustain efficient human-to-human spread except for the Andes virus strain, which requires prolonged close contact and has caused only limited clusters. The May 2026 Andes virus outbreak aboard the MV Hondius cruise ship produced roughly 12 cases and three deaths before containment, with CDC and WHO assessments confirming very low global risk due to the absence of sustained community transmission or mutations enabling airborne spread. Official surveillance through August 2026 shows no escalation beyond isolated incidents, consistent with historical patterns of focal outbreaks rather than pandemics. Trader consensus at 96% for no pandemic in 2026 reflects this epidemiological profile and lack of enabling conditions. A realistic shift could occur only from unexpected viral evolution boosting transmissibility or an unprecedented rodent-driven surge overwhelming containment, though current data indicate these thresholds remain distant.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions